Walgreens Boots Alliance Inc. (NASDAQ:WBA) declared a quarterly dividend on Thursday, October 13th. Stockholders of record on Thursday, November 17th will be given a dividend of 0.375 per share by the pharmacy operator on Monday, December 12th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date is Tuesday, November 15th.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.05 on Monday. Walgreens Boots Alliance has a 12-month low of $71.50 and a 12-month high of $87.05. The company has a market capitalization of $87.80 billion, a PE ratio of 21.22 and a beta of 1.19. The stock has a 50 day moving average of $80.51 and a 200-day moving average of $80.87.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.08. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The firm had revenue of $28.60 billion for the quarter, compared to analysts’ expectations of $29.06 billion. During the same quarter last year, the company earned $0.88 EPS. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. Equities analysts expect that Walgreens Boots Alliance will post $5.01 earnings per share for the current year.

Dividend History for Walgreens Boots Alliance (NASDAQ:WBA)

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,067 shares of the business’s stock in a transaction that occurred on Wednesday, November 2nd. The stock was sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the sale, the director now owns 24,623 shares in the company, valued at $2,001,849.90. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Stefano Pessina acquired 2,000,000 shares of Walgreens Boots Alliance stock in a transaction on Friday, November 4th. The stock was purchased at an average price of $81.41 per share, with a total value of $162,820,000.00. The disclosure for this purchase can be found here. Corporate insiders own 21.10% of the company’s stock.

Large investors have recently modified their holdings of the stock. Calvert Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 2.8% in the second quarter. Calvert Investment Management Inc. now owns 64,619 shares of the pharmacy operator’s stock worth $5,381,000 after buying an additional 1,776 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 2.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 2,558,843 shares of the pharmacy operator’s stock worth $213,075,000 after buying an additional 62,061 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Walgreens Boots Alliance by 7.2% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 212,724 shares of the pharmacy operator’s stock worth $17,714,000 after buying an additional 14,250 shares in the last quarter. Wealthfront Inc. boosted its stake in shares of Walgreens Boots Alliance by 11.2% in the second quarter. Wealthfront Inc. now owns 12,144 shares of the pharmacy operator’s stock worth $1,011,000 after buying an additional 1,221 shares in the last quarter. Finally, Stifel Financial Corp purchased a new stake in shares of Walgreens Boots Alliance during the second quarter worth $66,411,000. Institutional investors own 59.92% of the company’s stock.

A number of research analysts have weighed in on WBA shares. Zacks Investment Research lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Thursday, October 6th. Robert W. Baird reiterated an “outperform” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Tuesday, October 4th. Bank of America Corp. reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. Wells Fargo & Co. started coverage on Walgreens Boots Alliance in a report on Monday, October 31st. They set an “outperform” rating on the stock. Finally, Deutsche Bank AG lifted their price target on Walgreens Boots Alliance from $93.00 to $94.00 and gave the stock a “buy” rating in a report on Tuesday, August 30th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and an average target price of $90.30.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.